Description: Monkey (Cynomolgus) lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Cynomolgus) lung tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Description: Monkey (Rhesus) lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The monkey (Rhesus) lung tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Description: Rabbit lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The rabbit lung tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Description: Primary antibody against Lung Specific Antigen(LSA120), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), Concentration: 0.2mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), Concentration: 0.2mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), PerCP conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), 1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Lung Specific Antigen(LSA120), CF405S conjugate, Concentration: 0.1mg/mL

Description: Human lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human lung tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Description: Fetal human lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human lung tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Description: Human lung tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human lung tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated lung tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated lung tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Description: Fresh tissue lysate isolated from human lung

Description: Lung tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Description: Lung tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Description: Lung tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Description: Lung tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.